Security key
00857U107
agilon health, inc. - Common stock, $0.01 par value (AGL)
CUSIP: 00857U107
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common stock, $0.01 par value
- Total 13F shares
- 399,328,682
- Total 13F value
- $918,636,706
- Share change
- -461,593
- Put/Call ratio
- 118%
- SEC-reported price per share
- $2.30
- Number of holders
- 204
- Value change
- -$2,996,581
- Number of buys
- 116
- Number of sells
- 74
- Shares outstanding
- 16,608,126
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
204
Top holders
10
AGL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
agilon health, inc. SEC filings
agilon health, inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00857U107
Recent filing periods:
Ownership snapshot
Top reported holders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
Clayton, Dubilier & Rice,...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 12%
13D/G row: MORGAN STANLEY
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
12%
WELLINGTON MANAGEMENT GROUP LLP
3.6%
Capital International Investors
2.4%
Clayton, Dubilier & Rice, LLC
602%
Capital World Investors
322%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
13D/G
Company
|
12%
from 13D/G
|
$225,305,933
52,033,701 shares
|
— | 31 Mar 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
Company
|
3.6%
from 13D/G
|
$64,893,264
14,986,897 shares
|
— | 31 Mar 2025 |
| Capital International Investors |
13F
13D/G
Company
|
2.4%
from 13D/G
|
$96,697,010
22,331,873 shares
|
— | 31 Mar 2025 |
| Clayton, Dubilier & Rice, LLC |
13F
Company
|
602%
|
$433,000,000
100,000,000 shares
|
— | 31 Mar 2025 |
| Capital World Investors |
13F
Company
|
322%
|
$231,252,029
53,406,935 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
182%
|
$131,137,341
30,285,760 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
204
Shares
399,328,682
Rows available
204
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
198
Q2 2025 holders
204
Holder diff
6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend